| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |